2.2 A phase II trial with canakinumab, a new IL-1beta blocking monoclonal antibody (ACZ885), to evaluate preliminary dosing, safety and efficacy profile in children with systemic Juvenile Idiopathic arthritis (sJIA)

Saved in:

Bibliographic Details
Main Authors:	Ruperto N (Author), Quartier P (Author), Wulffraat N (Author), Woo P (Author), Loy A (Author), Mouy R (Author), Bader-Meunier B (Author), Prakken B (Author), Noseda E (Author), Rordorf C (Author)
Format:	Book
Published:	BMC, 2008-09-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Internet

Holdings details from 3rd Floor Main Library
Call Number:	A1234.567
Copy 1	Available